Elekta (OTCMKTS:EKTAY) Shares Gap Up – Time to Buy?

Elekta AB (OTCMKTS:EKTAY)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $5.6310, but opened at $5.92. Elekta shares last traded at $5.92, with a volume of 2,538 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered Elekta from a “hold” rating to a “strong sell” rating in a report on Tuesday. Two equities research analysts have rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Elekta Stock Performance

The stock has a market capitalization of $2.17 billion, a PE ratio of -36.81 and a beta of 1.00. The stock has a fifty day moving average of $5.99 and a 200-day moving average of $6.03. The company has a quick ratio of 0.73, a current ratio of 0.95 and a debt-to-equity ratio of 0.56.

Elekta (OTCMKTS:EKTAY) last released its earnings results on Thursday, May 28th. The company reported $0.06 earnings per share (EPS) for the quarter. The firm had revenue of $521.00 million during the quarter. Elekta had a positive return on equity of 10.67% and a negative net margin of 3.32%. Equities analysts anticipate that Elekta AB will post 0.43 earnings per share for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.